first patient in nextherizon phase 2 clinical trial
Published 2 years ago • 412 plays • Length 5:20Download video MP4
Download video MP3
Similar videos
-
6:40
imugene doses first patient in vaxinia phase 1 trial
-
4:14
imugene (asx:imu) doses first patient in iv arm of phase 1 oncarlytics trial targeting solid cancers
-
5:00
imugene doses first patient in intravenous monotherapy arm of phase 1 clinical trial
-
4:00
first patient dosed in imugene's pd1-vaxx combination trial
-
19:03
imugene steps up dosage at groundbreaking vaxinia cancer trial
-
19:03
imugene steps up dosage at groundbreaking vaxinia cancer trial
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
5:30
imugene releases final data from phase 2 her vaxx study
-
4:56
asx to rebound. imugene trials first patient in nextherizon
-
4:45
imugene receives ethics approval to start phase 2 clinical trial
-
5:00
imugene doses first patient in intravenous monotherapy arm of phase 1 clinical trial
-
4:03
imugene doses first patient in phase-two study of cancer vaccine
-
2:30
imugene thrilled as first patient dosed in phase 1 oasis trial
-
9:34
imugene (asx: imu) – first patient dosed in checkvacc phase 1 trials
-
5:15
imugene | first patients dosed in vaxinia mast combination study
-
4:45
first cohort 3 patient dosed in checkvacc trial
-
10:00
imugene begins vaxinia trial for bile tract cancer
-
3:51
imugene limited (asx:imu) three complete responses in azer-cel phase 1b trial
-
3:07
imugene: serious inroads – a highly successful cancer drug trial